NCT04453501View on ClinicalTrials.gov

Anti Infective Agents Impact in COVID-19 Pneumonia

CompletedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

March 2, 2020

Primary Completion Date

April 25, 2020

Study Completion Date

April 25, 2020

Conditions
COVIDPneumonia, Viral
Interventions
DRUG

favorable outcome

Whether patient under such regimen had a favorable outcome (no transfer in intensive care unit or death)

Trial Locations (1)

92380

Benjamin Davido, Garches

All Listed Sponsors
lead

Centre d'Investigation Clinique et Technologique 805

OTHER

NCT04453501 - Anti Infective Agents Impact in COVID-19 Pneumonia | Biotech Hunter | Biotech Hunter